CHA Biotech Co. Ltd (085660) — Capital Reinvestment Ratio
CHA Biotech Co. Ltd (085660) has a Capital Reinvestment Ratio of 2.52x as of June 2024, meaning it reinvests 3% of its operating cash flow (₩13.77 Billion) in capital expenditures (₩34.71 Billion). See 085660 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CHA Biotech Co. Ltd Capital Reinvestment Ratio (2009–2023)
This chart tracks CHA Biotech Co. Ltd's Capital Reinvestment Ratio across 13 annual periods. Check 085660 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for CHA Biotech Co. Ltd (2009–2023)
Year-by-year Capital Reinvestment Ratio for CHA Biotech Co. Ltd from 2009 to 2023. For live market cap and broader valuation context, see CHA Biotech Co. Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 6.46x | ₩11.51 Billion | ₩74.38 Billion | ▲ +24.4% |
| 2021 | 5.19x | ₩22.23 Billion | ₩115.46 Billion | ▲ +93.4% |
| 2020 | 2.69x | ₩47.00 Billion | ₩126.23 Billion | ▼ -37.1% |
| 2019 | 4.27x | ₩25.24 Billion | ₩107.77 Billion | ▲ +311.9% |
| 2018 | 1.04x | ₩75.38 Billion | ₩78.14 Billion | ▼ -66.3% |
| 2017 | 3.07x | ₩12.01 Billion | ₩36.91 Billion | ▲ +1.7% |
| 2016 | 3.02x | ₩11.29 Billion | ₩34.13 Billion | ▲ +496.2% |
| 2015 | 0.51x | ₩61.86 Billion | ₩31.36 Billion | ▲ +20.8% |
| 2013 | 0.42x | ₩66.35 Billion | ₩27.85 Billion | ▼ -37.7% |
| 2012 | 0.67x | ₩45.77 Billion | ₩30.84 Billion | ▼ -8.2% |
| 2011 | 0.73x | ₩34.69 Billion | ₩25.48 Billion | ▲ +22.5% |
| 2010 | 0.60x | ₩42.07 Billion | ₩25.22 Billion | ▼ -19.7% |
| 2009 | 0.75x | ₩24.02 Billion | ₩17.93 Billion | — |